Oscar Health, Inc.

Oscar Health, Inc. Class A's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Oscar Health, Inc. Class A has 308.63M shares outstanding.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Oscar Health, Inc. Class A posted a return on equity (ROE) of 34.31, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 6.25, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 28.64, useful for judging operating efficiency across full business cycles. The company generates approximately 5.76M in revenue per employee across its workforce of 2,328.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Oscar Health, Inc. Class A recorded 34.03M in income tax expense. That works out to an effective tax rate of 6.59, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 516.26M, leaving 482.07M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Over the twelve months ended June 30, 2026, Oscar Health, Inc. Class A generated 13.41B in revenue and converted that into 482.07M in net income, yielding earnings per share of 1.60.

As of June 30, 2026, Oscar Health, Inc. Class A holds 7.49B in cash and equivalents against 377.80M in total debt, resulting in a net debt position of -3.19B.

Oscar Health, Inc. Class A produced 3.87B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -33.81M in capital expenditures, free cash flow totaled 3.83B - equivalent to 13.42 per share.

These figures cover the twelve months ended June 30, 2026.